Clinical trial
Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome
NCT00316550 · Avera Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00316550 |
|---|---|
| Title | Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Pilot Study to Assess the Effects of AV608 on Central Processing of Visceral Stimuli in Subjects With Irritable Bowel Syndrome |
| Lead sponsor | Avera Pharmaceuticals, Industry |
| Collaborators | University of California, Los Angeles |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Irritable Bowel Syndrome (IBS) |
| Intervention type | Drug |
| Interventions | AV608 |
| Enrollment | 24 |
| Start date | Apr 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 21, 2006 |
| Last update posted | Feb 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: